Merck
MRK
#48
Rank
S$412.18 B
Marketcap
S$166.89
Share price
0.32%
Change (1 day)
65.81%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$4.58

According to Merck's latest financial reports the company's current EPS (TTM) is S$4.58. In 2025 the company made an earnings per share (EPS) of S$9.37 an increase over its 2024 EPS that were of S$8.66.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.58-51.12%
2025S$9.378.15%
2024S$8.664308.46%
2023S$0.20-97.32%
2022S$7.3410.92%
2021S$6.6284.68%
2020S$3.59-27.2%
2019S$4.9263.44%
2018S$3.01151.11%
2017S$1.20-54.58%
2016S$2.6430.21%
2015S$2.03-61.99%
2014S$5.34180.51%
2013S$1.90-31.82%
2012S$2.796.62%
2011S$2.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.20 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.00 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.68-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.63 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.18 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.56 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.28-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$4.56-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.98 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.76-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel